Skip to main content

Table 4 Sociodemographic and scores means of QoL domains of TB patients

From: Survey to measure the quality of life of patients with tuberculosis in Alexandria, Egypt: a cross-sectional study

 

Physical domain

Score

Psychological

Domain score

Social

Domain score

Environmental

Domain score

Gender

    

 Male (134)

 Female (46)

P value

42.4 ± 18.6

43 ± 19.7

0.67

42.6 ± 16

43.4 ± 16.8

0.79

20.4 ± 1.8

20.8 ± 3.1

0.70

45.5 ± 12.6

45.3 ± 14.6

0.90

Age groups:

    

 18–30 (52)

 31–40(56)

 41–50(37)

 51–60(24)

 61–75 (11)

P value

45.9 ± 19.9

40.1 ± 15.6

41.5 ± 19.8

44.2 ± 20.2

42.5 ± 22.5

0.58

46.3 ± 18.5

39.5 ± 13

43 ± 17.2

42.5 ± 14.5

42.8 ± 17.7

0.29

55.1 ± 20.7

47.2 ± 18.8

50.2 ± 22.4

46.5 ± 19.3

55.3 ± 21.2

0.23

50.2 ± 14.9

41.9 ± 10.9

45 ± 13.9

44.5 ± 10.7

43.4 ± 11.1

0.02*

Marital status

    

 Married (98)

 Single (82)

P value

42.2 ± 18.9

43.5 ± 18.7

0.65

41.4 ± 16.0

44.6 ± 16.2

0.19

49.8 ± 20.9

51.3 ± 20.0

0.63

44.0 ± 12.2

47.1 ± 14.0

0.11

Residence

    

 Urban (150)

 Rural (30)

P value

43.6 ± 18.8

38.5 ± 18.3

0.17

42.9 ± 16.5

42.4 ± 14.4

0.86

49.9 ± 21.2

53.6 ± 16.2

0.37

49.9 ± 21.2

53.6 ± 16.2

0.31

Education level

    

 Senior (45)

 Middle (40)

 Ignorant (35)

 Junior (28)

 Graduate (19)

 Read and write (13)

P value

43.7 ± 19.6

41.6 ± 19.7

38.4 ± 18.1

41.2 ± 14.3

51.5 ± 20.9

45.9 ± 19.1

0.24

44.2 ± 17.3

45.1 ± 16.7

39.0 ± 16.4

39.3 ± 15.7

45.8 ± 15.4

44.6 ± 9.5

0.40

49.6 ± 19.9

48.5 ± 20.6

48.6 ± 24.4

53.0 ± 17.5

52.2 ± 23.2

57.1 ± 12.7

0.76

45.5 ± 14,8

46.5 ± 12.3

43.3 ± 12.7

47.4 ± 13.4

44.1 ± 13.6

45.4 ± 9.9

0.85

Socioeconomic class

    

 Low (41)

 Medium (129)

 High (10)

P value

39.8 ± 18.4

43.7 ± 17.9

42.5 ± 30.0

0.51

40.9 ± 43.7

43.7 ± 15.9

39.6 ± 22.2

0.50

50.4 ± 20.2

51.1 ± 20.2

43.3 ± 25.1

0.51

45.0 ± 12.1

45.9 ± 13.4

41.3 ± 13.6

0.55

TB type

    

 Pulmonary TB (129)

 Extrapulmonary TB (51)

P value

42.2 ± 19.1

44.3 ± 18.0

0.49

42.5 ± 16.3

43.5 ± 15.8

0.71

49.7 ± 20.8

52.5 ± 19.8

0.43

45.1 ± 13.3

46.2 ± 12.8

0.60

Disease duration

    

 ≤ 6 months (94)

 > 6 months (86)

P value

42.7 ± 19.9

42.8 ± 17.7

0.98

43.3 ± 15.7

42.3 ± 16.6

0.68

50.6 ± 22.7

50.4 ± 17.8

0.93

45.9 ± 14

44.9 ± 12.1

0.61

Treatment phase

    

 Intensive phase(81)

 Continuation phase (99)

P value

40.9 ± 20.5

44.3 ± 17.2

0.22

41.1 ± 16.7

44.2 ± 15.6

0.20

49.3 ± 22.3

51.5 ± 18.9

0.47

43.9 ± 14,1

46.7 ± 12.1

0.17

MDR

    

 MDR (18)

 Not MDR (162)

P value

44.0 ± 20.4

42.6 ± 18.7

0.67

43.1 ± 16.8

42.6 ± 18.7

0.95

48.6 ± 20.7

50.7 ± 20.5

0.68

44.4 ± 12.2

45.5 ± 13.2

0.74

Chronic diseases

    

 Present (64)

 Absent (116)

P value

43.5 ± 20.8

42.4 ± 17.7

0.69

44.3 ± 17.1

42.0 ± 15.6

0.37

53.3 ± 20.6

49.0 ± 20.3

0.18

47.3 ± 13.5

44.4 ± 12.8

0.15